Bao Hou, Shijie Zhang, Yuanyuan Wen, Anjing Xu, Xuexue Zhu, Weiwei Cai, Yuetao Zhou, Liying Qiu, Haijian Sun
{"title":"Self-Assembled HYP Liposome Nanoparticles Promote Diabetic Wound Healing by Regulating the Polarization of M1 Macrophages","authors":"Bao Hou, Shijie Zhang, Yuanyuan Wen, Anjing Xu, Xuexue Zhu, Weiwei Cai, Yuetao Zhou, Liying Qiu, Haijian Sun","doi":"10.1002/adtp.202400011","DOIUrl":null,"url":null,"abstract":"<p>Suppression of the polarization of M1 macrophages is crucial for promoting diabetic wound healing. Hypahorine (HYP), a small molecule alkaloid compound with anti-inflammatory properties, is encapsulated in liposome nanospheres (HYP-INPS) using a one-step ultrasound method and applied to treat open wounds in diabetic rats. Transmission electron microscopy (TEM) revealed that HYP-INPS nanoparticles are spherical and coated with a lipid layer. ZetaPALS analysis demonstrated that HYP-INPS has a potential of -15.67 ± 2.58 mV and a size of 212.87 ± 13.34 nm. In vitro, confocal microscopy revealed the cellular uptake of HYP-INPS in macrophages. Flow cytometry showed that HYP-INPS inhibited the polarization of bone marrow-derived macrophages (BMDMs) to the M1 phenotype. In vivo, HYP-INPS promoted diabetic wound healing by improving the inflammatory microenvironment within wounds. Immunofluorescence revealed that HYP-INPS up-regulated the expression of M2 macrophages and down-regulated the expression of M1 macrophages at the wound site. Transcriptome sequencing showed that HYP-INPS treatment specifically up-regulated ASB10 expression in LPS-induced RAW264.7 cells. Loss-of-function or gain-of-function experiments confirmed the regulatory role of ASB10 in M1 macrophage polarization. Therefore, HYP-INPS targeted ASB10 is concluded to accelerate wound healing in diabetes by inhibiting the polarization of M1 macrophages and improving the inflammatory microenvironment. This newly developed HYP-INPS system holds promise as a potential treatment for diabetic wounds.</p>","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"7 8","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adtp.202400011","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Suppression of the polarization of M1 macrophages is crucial for promoting diabetic wound healing. Hypahorine (HYP), a small molecule alkaloid compound with anti-inflammatory properties, is encapsulated in liposome nanospheres (HYP-INPS) using a one-step ultrasound method and applied to treat open wounds in diabetic rats. Transmission electron microscopy (TEM) revealed that HYP-INPS nanoparticles are spherical and coated with a lipid layer. ZetaPALS analysis demonstrated that HYP-INPS has a potential of -15.67 ± 2.58 mV and a size of 212.87 ± 13.34 nm. In vitro, confocal microscopy revealed the cellular uptake of HYP-INPS in macrophages. Flow cytometry showed that HYP-INPS inhibited the polarization of bone marrow-derived macrophages (BMDMs) to the M1 phenotype. In vivo, HYP-INPS promoted diabetic wound healing by improving the inflammatory microenvironment within wounds. Immunofluorescence revealed that HYP-INPS up-regulated the expression of M2 macrophages and down-regulated the expression of M1 macrophages at the wound site. Transcriptome sequencing showed that HYP-INPS treatment specifically up-regulated ASB10 expression in LPS-induced RAW264.7 cells. Loss-of-function or gain-of-function experiments confirmed the regulatory role of ASB10 in M1 macrophage polarization. Therefore, HYP-INPS targeted ASB10 is concluded to accelerate wound healing in diabetes by inhibiting the polarization of M1 macrophages and improving the inflammatory microenvironment. This newly developed HYP-INPS system holds promise as a potential treatment for diabetic wounds.